Altice CK, Banegas MP, Tucker-Seeley RD, . Financial hardships experienced by cancer survivors: a systematic review. J Natl Cancer Inst 2016;109:djw205.
Zafar SY, Peppercorn JM, Schrag D, . The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient’s experience. Oncologist 2013;18:381–390.
Shankaran V, Jolly S, Blough D, . Risk factors for financial hardship in patients receiving adjuvant chemotherapy for colon cancer: a population-based exploratory analysis. J Clin Oncol 2012;30:1608–1614.
Khera N, Chang YH, Hashmi S, . Financial burden in recipients of allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 2014;20:1375–1381.
Jagsi R, Pottow JAE, Griffith KA, . Long-term financial burden of breast cancer: experiences of a diverse cohort of survivors identified through population-based registries. J Clin Oncol 2014;32:1269–1276.
Kent EE, Forsythe LP, Yabroff KR, . Are survivors who report cancer-related financial problems more likely to forgo or delay medical care? Cancer 2013;119:3710–3717.
Kodama Y, Morozumi R, Matsumura T, . Increased financial burden among patients with chronic myelogenous leukaemia receiving imatinib in Japan: a retrospective survey. BMC Cancer 2012;12:152.
Huntington SF, Weiss BM, Vogl DT, . Financial toxicity in insured patients with multiple myeloma: a cross-sectional pilot study. Lancet Haematol 2015;2:e408–416.
Abel GA, Albelda R, Khera N, . Financial hardship and patient-reported outcomes after hematopoietic cell transplantation. Biol Blood Marrow Transplant 2016;22:1504–1510.
Chino F, Peppercorn J, Taylor DH Jr, . Self-reported financial burden and satisfaction with care among patients with cancer. Oncologist 2014;19:414–420.
Fenn KM, Evans SB, McCorkle R, . Impact of financial burden of cancer on survivors’ quality of life. J Oncol Pract 2014;10:332–338.
Kelley RK, Venook AP. Nonadherence to imatinib during an economic downturn. N Engl J Med 2010;363:596–598.
Khera N, Holland JC, Griffin JM. Setting the stage for universal financial distress screening in routine cancer care. Cancer 2017;123:4092–4096.
de Souza JA, Yap BJ, Wroblewski K, . Measuring financial toxicity as a clinically relevant patient-reported outcome: the validation of the COmprehensive Score for financial Toxicity (COST). Cancer 2017;123:476–484.
Dusetzina SB, Basch E, Keating NL. For uninsured cancer patients, outpatient charges can be costly, putting treatments out of reach. Health Aff (Millwood) 2015;34:584–591.
Ramsey SD, Bansal A, Fedorenko CR, . Financial insolvency as a risk factor for early mortality among patients with cancer. J Clin Oncol 2016;34:980–986.
Yabroff KR, Dowling EC, Guy GP Jr, . Financial hardship associated with cancer in the United States: findings from a population-based sample of adult cancer survivors. J Clin Oncol 2016;34:259–267.
Smith SK, Nicolla J, Zafar SY. Bridging the gap between financial distress and available resources for patients with cancer: a qualitative study. J Oncol Pract 2014;10:e368–372.
Schrag D, Hanger M. Medical oncologists’ views on communicating with patients about chemotherapy costs: a pilot survey. J Clin Oncol 2007;25:233–237.
Ubel PA, Zhang CJ, Hesson A, . Study of physician and patient communication identifies missed opportunities to help reduce patients’ out-of-pocket spending. Health Aff (Millwood) 2016;35:654–661.
Altomare I, Irwin B, Zafar SY, . ReCAP: physician experience and attitudes toward addressing the cost of cancer care. J Oncol Pract 2016;12:247–248.
Rosenstock IM, Strecher VJ, Becker MH. Social learning theory and the Health Belief Model. Health Educ Q 1988;15:175–183.
Coluzzi PH, Grant M, Doroshow JH, . Survey of the provision of supportive care services at National Cancer Institute-designated cancer centers. J Clin Oncol 1995;13:756–764.
Jacobsen PB, Ransom S. Implementation of NCCN Distress Management Guidelines by member institutions. J Natl Compr Canc Netw 2007;5:99–103.
Association of Community Cancer Centers. 2014 Trends Survey. Accessed February 19, 2020. Available at: https://www.accc-cancer.org/home/learn/publications/Trends/2014
Nipp RD, Powell E, Chabner B, . Recognizing the financial burden of cancer patients in clinical trials. Oncologist 2015;20:572–575.
Aakhus E, Rosenstein A, Joffee S, Bradbury AR. Implementing cost transparency in oncology: a qualitative study of barriers, facilitators, and patient preferences [abstract]. J Clin Oncol 2017;35(Suppl):Abstract 6597.
- Search Google Scholar
- Export Citation
)| false . , Aakhus E , Rosenstein A , Joffee S Bradbury AR Implementing cost transparency in oncology: a qualitative study of barriers, facilitators, and patient preferences [abstract]. J Clin Oncol 2017; 35( Suppl): Abstract 6597. 10.1200/JCO.2017.35.15_suppl.6597
Bullock AJ, Hofstatter EW, Yushak ML, . Understanding patients’ attitudes toward communication about the cost of cancer care. J Oncol Pract 2012;8:e50–58.
Shankaran V, Leahy T, Steelquist J, . Pilot feasibility study of an oncology financial navigation program. J Oncol Pract 2018;14:e122–129.